{"nct_id":"NCT03871348","title":"A First-in-Human Dose Escalation and Expansion Study to Evaluate Intratumoral Administration of SAR441000 as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors","status":"TERMINATED","status_verified_date":"2025-09","start_date":"2019-01-03","start_date_type":"ACTUAL","primary_completion_date":"2022-07-25","primary_completion_date_type":"ACTUAL","completion_date":"2024-02-21","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["SNY"]}